Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 20, 2007

Chromos and Pain Thearapeutics Okay Cell Line Engineering Agreement

  • Chromos Molecular Systems inked a cell line development deal with Pain Therapeutics. It will engineer cell lines specific for the expression of a Mab for Pain Therapeutics using the ACE System.

    Pain Therapeutics has the right to use the cell lines for scale up and manufacture of the Mab, following the cell line engineering phase of the agreement.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »